Completed OBSERVATIONAL NCT01197742

Sweetheart-Register: Risk Management of Diabetics with Acute Myocardial Infarction (Sweetheart)

Sweetheart: Risiko-Management Von Diabetikern Mit Akutem Myokardinfarkt

Sponsor: Sanofi

Conditions Diabetes Myocardial Infarction NSTEMI STEMI

Updated 9 times since 2017 Last updated: Dec 18, 2024 Started: Apr 20, 2007 Primary completion: Oct 5, 2009 Completion: Oct 5, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes and Myocardial Infarction, this trial is completed. The trial is conducted by Sanofi and has accumulated 9 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Feb 2025 — Sep 2025 [monthly]

Completed
Jan 2025 — Feb 2025 [monthly]

Completed
Sep 2024 — Jan 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed

▶ Show 4 earlier versions

Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanofi
Stiftung Institut fuer Herzinfarktforschung

Data source: Stiftung Institut fuer Herzinfarktforschung

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• München, Germany
• Nuremberg, Germany